Clinical Trials Browser

Anemia, Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT00883181 2017-03-15

A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy

Completed

1,370 enrolled 56 charts

BreastGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Small Cell Lung Carcinoma

NCT01459653 2016-01-11

Monitor-GCSF

Completed

1,496 enrolled 120 charts

BreastClassical hematologyGenitourinaryGynecologicLymphoidPlasma cellThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Lung Neoplasms, Multiple Myeloma, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Lymphoma, B-Cell, Febrile Neutropenia

NCT00746694 2015-08-27

A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020)

Completed

154 enrolled 7 charts

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Paresthesia

NCT00743431 2015-04-15

Caelyx in Ovarian Cancer: Prevention and Treatment of Infusion Reactions and Palmar-plantar Erythrodysesthesia (Study P04085)(COMPLETED)

Completed

224 enrolled 6 charts

Gynecologic

Ovarian Neoplasms

Clinical Trials

TORCH

Assessing the Time Demands of Cancer

PRIORITY

CLOCS

NIMES-ROC

Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors.

nCYT

Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life

Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia

A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy

Monitor-GCSF

A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020)

Caelyx in Ovarian Cancer: Prevention and Treatment of Infusion Reactions and Palmar-plantar Erythrodysesthesia (Study P04085)(COMPLETED)